Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Palliative treatment of chronic myeloid leukemia
Age: Adult
Dose: Oral – 60 mcg/kg
Frequency: daily
Indication: Palliative treatment of chronic myeloid leukemia
Age: Adult
Condition: Maintenance
Dose: Oral – 0.5-2 mg
Frequency: daily
Note: Maximum: 4 mg daily

Child Dose

Clinical InformationAdministration Information
Indication: Conditioning treatment prior to conventional haematopoietic progenitor cell transplantation
Age: 0 to 17 years
Dose: Intravenous infusion – 1.0 mg/kg
Frequency: every 6 hours
Duration: 4 consecutive days
Note: total 16 doses
Indication: Conditioning treatment prior to conventional haematopoietic progenitor cell transplantation
Age: 0 to 17 years
Dose: Intravenous infusion – 1.2 mg/kg
Frequency: every 6 hours
Duration: 4 consecutive days
Note: total 16 doses
Administration
  • Can be taken with or without food
  • Take with cool liquid
Side Effect

Drug Interaction

Drug NameRisk Factors
Cyclophosphamide, itraconazole
Decreased clearance
Phenytoin
Increased clearance

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Tab: Store below 25°C.
Inj concentrate: Store between 2-8°C.
Do not freeze.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.